Join the uMed Research Network

Play your part in advancing medical research.

Get started

  • Over 450 GP practices use uMed to participate in clinical research
  • Enroled 6,000+ patients in clinical research
  • Only 10 minutes of your time is required to participate in a study
  • Generate additional revenue for your practice

Set-up support

If you would like to join our Research Network

Fill in your details on the right to book a call with our support team so we can discuss requirements for your specific organisation and help you to get started with the onboarding process.

If you are part of an ongoing uMed-supported study and would like support, please contact us here.

Book a meeting with our support team to discuss set-up with the uMed platform.

An error occurred. Please reload an try again.

Get started

  • 400 GP practices use uMed to participate in clinical research
  • Enrolled 4,000+ patients in clinical research
  • Only 10 minutes of your time is required to participate in a study
  • Generate additional revenue for your practice

Why do we need your practice ODS code?

We need to verify your practice’s unique code created by the Organisation Data Service within NHS Digital.

This is used to identify organisations across health and social care to ensure we have the right information.

Why do we need your practice details?

We need to verify your practice’s unique code created by the Organisation Data Service within NHS Digital.

This is used to identify organisations across health and social care to ensure we have the right information.

Please enter your practice details below so we can identify your practice as eligible for registering with uMed.

Why do we need your practice ODS code?

We need to verify your practice’s unique code created by the Organisation Data Service within NHS Digital.

This is used to identify organisations across health and social care to ensure we have the right information.

An error occurred. Please reload and try again.

{{ practiceAddress }}

EHR system

uMed has agreements with EHR providers in the UK, such as EMIS and SystmOne.

close Created with Sketch.

Why do we need your EHR system?

In order for us to perform searches of EHR records on your behalf to provide research services for you, we need to activate an EHR request.

EHR system

uMed has agreements with EHR providers in the UK, such as EMIS and SystmOne.

If your practice is registered with the EMIS system, please enter your CBD code.

close Created with Sketch.

Why do we need your CBD code?

In order for us to activate the EMIS agreement, we need your EMIS CBD code, this is a unique number given to you by EMIS.

You may know it as your EMIS customer number.

Who would know the CBD code?

You should be able to find this on EMIS Web or alternatively, contact your practice manager.

Last step…

We’ve gone above and beyond to exceed data security requirements.

  • We conform to the requirements of General Data Protection Regulation (UK GDPR) as well as the NHS Data Protection & Security Toolkit
  • ISO27001:2013, ISO9001:2015 compliant and Cyber Essentials Plus Certified
  • Our Data Processing Agreement has been independently reviewed by Wessex CRN legal team
  • We have Data Processing Agreements in place with 400 GP practices in the UK

Want more information? Download our Information governance pack here.

If you have any Information Governance related questions, view our FAQ’s here or alternatively, speak to a member of our support team.

We want you to feel secure that your data is being handled transparently, so we ask each practice to sign our Data Processing Agreement.

Please provide the details of the person that will be responsible for signing the data processing agreement and we will send them the document by email.

close Created with Sketch.

Why do we need a data processing agreement?

uMed provides services to the practice that support the execution of clinical studies. This requires an agreement between uMed and the practice in addition to usual research agreement between the study team and site.

close Created with Sketch.

Who should sign the data processing agreement?

The GP partner, research lead or practice manager will usually be responsible for signing the Data Processing Agreement.

EHR system

uMed has agreements with EHR providers in the UK, such as EMIS and SystmOne.

If your practice is registered with the SystmOne (TPP), please provide the following details.

chevron-down Created with Sketch.

EHR system

uMed has agreements with EHR providers in the UK, such as EMIS and SystmOne.

If your practice is registered with the SystmOne (TPP), please provide the following details.

close Created with Sketch.

Where can I find my TPP Organisation ID?

You can find your TPP organisation ID by selecting Shift + F12 in SystmOne, and then selecting 'System information' from the set-up drop down menu. If you do not have access to SystmOne, ask your practice manager or external IT help desk.

close Created with Sketch.

Who is my SystmOne administrator?

The administrator for SystmOne is usually the Practice Manager. Alternatively contact your IT Help desk to find this information.

Thank you

Thank you for registering your interest. We will be in touch soon.

What’s next?

Thank you for requesting the uMed Data Processing Agreement, a DocuSign agreement has been sent to the stated person responsible for signing this agreement.

Upon digitally signing this agreement, our team will be in touch with a training video and password.

Your practice will then be able to start participating in a uMed study.

You can find more information about the interventional and observational studies that uMed are currently supporting below.

uMed Studies

  • Treatment Area:

    Cardiometabolic Disease

  • Study Aim:

    To advance our understanding of Cardiometabolic Disease and accelerate the development of advanced therapies to improve outcomes for patients

  • Recruitment Target:

    Ongoing recruitment of patient's diagnosed with Cardiometabolic Disease

See Study Details Right Arrow
  • Treatment Area:

    Interstitial Lung Diseases (ILD)

  • Study Aim:

    To advance our understanding of Interstitial Lung Disease and accelerate the development of advanced therapies to improve outcomes for patients

  • Recruitment Target:

    Ongoing patient recruitment of patient's diagnosed with Interstitial Lung Disease

See Study Details Right Arrow
  • Treatment Area:

    Parkinson's Disease

  • Study Aim:

    To advance our understanding of Parkinson’s Disease and accelerate the development of advanced therapies to improve outcomes for patients

  • Recruitment Target:

    Ongoing recruitment of patient's diagnosed with Parkinson's Disease

See Study Details Right Arrow
  • Treatment Area:

    Asthma

  • Trial Site Locations:

    Glenfield Hospital, Leicester

    Queen Anne Street, London

    Lakeside Healthcare, Corby

    Imperial College Healthcare NHS Trust, London

  • Study Aim:

    To investigate the efficacy and safety of a new investigational medication (Atuliflapon) in adults with moderate to severe uncontrolled asthma

  • Recruitment Target:

    34 patients

See Study Details Right Arrow
  • Treatment Area:

    COPD

  • Trial Site Locations:
    Clinical Research Facility Bradford Royal Infirmary Bradford Queen Anne Street Medical Centre - London Panthera Biopartners - Rochdale
  • Study Aim:

    To assess whether two doses of CHF6001 DPI add-on to maintenance triple therapy can reduce the occurrence of these COPD exacerbations.

  • Recruitment Target:

    10 patients

See Study Details Right Arrow
  • Treatment Area:

    Respiratory Syncytial Virus (RSV)

  • Trial Site Locations:

    Fylde Coast Clinical Research Blackpool

    Royal Devon University Healthcare NHS Foundation Trust

    Royal Free Hospital London

    Liverpool School of Tropical Medicine

  • Study Aim:

    To evaluate the safety and immune response of an investigational vaccine (mRNA-1345) aimed at preventing RSV infection in high risk adults

  • Recruitment Target:

    100 patients

See Study Details Right Arrow
  • Treatment Area:

    Parkinson's Disease

  • Trial Site Locations:
    Newcastle University, Campus for Ageing and Vitality.
  • Study Aim:

    This study, run by The Michael J. Fox Foundation for Parkinson’s Research, is exploring the link between loss of smell and brain disease by providing study participants with a simple scratch-and-sniff test.

  • Recruitment Target:

    15,000 patients without Parkinson's Disease.

See Study Details Right Arrow

Hear from our current network...

"Modality is a super partnership with 45 practices and about 450,000 registered list size and as a National Research Lead for Modality Partnership, I am thrilled to be working with Umed. They allow us to support our patients by promoting and developing clinical research across all Modality sites.”

Hear what patients think about uMed...

"When I first got the message from my GP I wasn’t sure if I was going to sign up as I’m not very good with the internet. But I called the Helpline and the Nurse explained everything to me and I’m really happy that I called. I’m looking forward to being part of Access PD"